Soft Tissue Allografts Market - Top Companies and Manufacturers

  • Report ID: 4344
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Companies Dominating the Soft Tissue Allografts Landscape

    • Stryker Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • ALON SOURCE GROUP
    • CONMED Corporation
    • LifeSciences Corporation
    • Organogenesis Inc.
    • RTI Surgical, Inc.
    • MIMEDX, Inc.
    • Xtant Medical Holdings, Inc.
    • Globus Medical, Inc.
    • Bone Bank Allografts

Browse Key Market Insights with Data Illustration:

In the News

  •  AlloSource, one of the leading providers of allograft in the United States, announced the launch of AlloMend Extra Large (XL) Acellular Dermal Matrix (ADM). It is so far the biggest dermal graft launched by the company. It is available in mesh and non-mesh variations for use in demanding soft tissue applications.

  • RTI Surgical, Inc. and Zimmer Biomet partnered with the American Academy of Implant Dentistry Foundation (AAIDF) to provide dental implants and wound care products for an initiative supporting veterans of the United States Armed Forces.

 


Author Credits:  Radhika Pawar


  • Report ID: 4344
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of soft tissue allografts is assessed at USD 4.53 Billion.

The soft tissue allografts market size was valued at USD 4.27 Billion in 2023 and is expected to reach USD 10.05 Billion by the end of 2036, expanding at around 6.8% CAGR during the forecast period i.e., between 2024-2036. Growing incidences of sports injuries, rising prevalence of osteoarthritis, increase in trauma cases, and upsurge in musculoskeletal diseases are the major factors driving the market growth.

North America is set to account for largest industry share by 2036, attributed to rising prevalence of arthritis, and rising healthcare expenditure on its treatment.

Stryker Corporation, ALON SOURCE GROUP, CONMED Corporation, LifeSciences Corporation, Organogenesis Inc., RTI Surgical, Inc., MIMEDX, Inc., Xtant Medical Holdings, Inc., Globus Medical, Inc., Bone Bank Allografts
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample